Igcasan, Mary Jane .

HRN: 22-79-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2023
CEFUROXIME 500MG (TAB)
08/18/2023
08/24/2023
ORAL
500mg
BID
RMLE, With Repair
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: